JP2018528262A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528262A5
JP2018528262A5 JP2018526282A JP2018526282A JP2018528262A5 JP 2018528262 A5 JP2018528262 A5 JP 2018528262A5 JP 2018526282 A JP2018526282 A JP 2018526282A JP 2018526282 A JP2018526282 A JP 2018526282A JP 2018528262 A5 JP2018528262 A5 JP 2018528262A5
Authority
JP
Japan
Prior art keywords
emollient
oxide
composition
carbonate
hydroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526282A
Other languages
English (en)
Japanese (ja)
Other versions
JP6856642B2 (ja
JP2018528262A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/050704 external-priority patent/WO2017020087A1/en
Publication of JP2018528262A publication Critical patent/JP2018528262A/ja
Publication of JP2018528262A5 publication Critical patent/JP2018528262A5/ja
Application granted granted Critical
Publication of JP6856642B2 publication Critical patent/JP6856642B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526282A 2015-08-04 2016-08-04 皮膚軟化組成物 Active JP6856642B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015903098 2015-08-04
AU2015903098A AU2015903098A0 (en) 2015-08-04 Emollient composition
PCT/AU2016/050704 WO2017020087A1 (en) 2015-08-04 2016-08-04 Emollient composition

Publications (3)

Publication Number Publication Date
JP2018528262A JP2018528262A (ja) 2018-09-27
JP2018528262A5 true JP2018528262A5 (enExample) 2019-09-05
JP6856642B2 JP6856642B2 (ja) 2021-04-07

Family

ID=57942176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526282A Active JP6856642B2 (ja) 2015-08-04 2016-08-04 皮膚軟化組成物

Country Status (11)

Country Link
US (1) US10596102B2 (enExample)
EP (1) EP3313369B1 (enExample)
JP (1) JP6856642B2 (enExample)
CN (1) CN108024946A (enExample)
AU (1) AU2016302401B2 (enExample)
CA (1) CA2994177C (enExample)
DK (1) DK3313369T3 (enExample)
ES (1) ES2824477T3 (enExample)
NZ (1) NZ739505A (enExample)
PL (1) PL3313369T3 (enExample)
WO (1) WO2017020087A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107041854A (zh) * 2017-05-27 2017-08-15 许昌学院 一种假发处理工人专用裂手霜及其制备方法
EP4608519A1 (en) * 2022-10-25 2025-09-03 AAK AB (publ) Uv filter composition comprising triterpenes, emollients and inorganic uv-filters

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012648A1 (en) * 1998-02-06 2002-01-31 Orthoefer Frank T. High phospholipid-containing dermatological compositions
GB0027674D0 (en) * 2000-11-13 2000-12-27 Johnson & Johnson Medical Ltd Hydrogel wound dressings
SE0201566D0 (sv) * 2002-05-27 2002-05-27 Karlshamns Ab New composition
US6911196B2 (en) * 2002-07-31 2005-06-28 Samir I. Hamtini Topical medicament for treating nappy rash
JP2005132753A (ja) * 2003-10-29 2005-05-26 Hideo Ogiwara 外皮用医薬組成物
US20080107751A1 (en) * 2004-03-10 2008-05-08 Jeff Hudnall Antimicrobial Wax Composition for Wax Therapy
US20090011042A1 (en) * 2005-07-26 2009-01-08 Global Life Technologies, Corp Antimicrobial and antiviral composition
US20080286390A1 (en) * 2007-05-16 2008-11-20 Judy Tanyi Skin care composition
US8623335B2 (en) * 2007-09-10 2014-01-07 Tauna Ann Waddington Scar and rosacea and other skin care treatment composition and method
WO2010018418A1 (en) * 2008-08-12 2010-02-18 Novatech D.O.O. Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon
US8846063B2 (en) * 2008-12-16 2014-09-30 Kimberly-Clark Worldwide, Inc. Personal care composition containing a volatile and a terpene alcohol
US8551517B2 (en) * 2008-12-16 2013-10-08 Kimberly-Clark Worldwide, Inc. Substrates providing multiple releases of active agents
US8673328B2 (en) * 2010-04-11 2014-03-18 Agnes Mwangi Blomberg Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water
EP3269372B1 (en) * 2012-01-19 2019-06-12 Hybrid Medical, LLC Topical therapeutic formulations
WO2014103475A1 (ja) * 2012-12-27 2014-07-03 株式会社林原 アンチエイジング用皮膚外用組成物及びその製造方法
KR102165385B1 (ko) * 2014-08-20 2020-10-15 사뮤메드, 엘엘씨 피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤
CN104800430A (zh) * 2015-05-23 2015-07-29 唐赢 一种改善睡眠深度的精油

Similar Documents

Publication Publication Date Title
JP2005508936A5 (enExample)
JP2016532722A5 (enExample)
WO2017025936A3 (en) Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
JP2017105763A5 (enExample)
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
PH12017502092A1 (en) Topical pharmaceutical compositions
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
WO2019035705A3 (es) Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel
JP2014505733A5 (enExample)
WO2010119369A3 (en) A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
WO2016137164A3 (ko) 바실러스 속 세균 유래 세포밖 소포체를 포함하는 임신관련 질환 치료용 조성물
EP4552650A3 (en) Methods and compositions for treatment of skin
WO2017083266A8 (en) Novel formulations
WO2019093673A3 (ko) 골질환 예방 또는 치료용 약학 조성물
WO2016142708A3 (en) Pharmaceutical composition
JP2018529666A5 (enExample)
JP2018528262A5 (enExample)
WO2023275413A3 (en) Solid pharmaceutical formulations of varenicline
JP2016210757A5 (enExample)
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
CA2926355C (en) Synergistic compositions with plant protection agents
EP3873480B1 (en) Anti-acne composition
JP2020525452A5 (enExample)
JP2018162320A5 (enExample)
MX2023010872A (es) Nueva composición tópica libre de tensioactivos derivados de sulfato.